Similar articles

• Clinical radiobiology of glottic T1 squamous cell carcinoma.

  Skladowski K, Tarnawski R, Maciejewski B, Wygoda A, Slosarek K. Skladowski K, et al. Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):101-6. doi: 10.1016/s0360-3016(98)00375-7. Int J Radiat Oncol Biol Phys. 1999. PMID: 9989520
• Accelerated radiotherapy for T1 to T2 glottic cancer.

  Motegi A, Kawashima M, Arahira S, Zenda S, Toshima M, Onozawa M, Hayashi R, Akimoto T. Motegi A, et al. Head Neck. 2015 Apr;37(4):579-84. doi: 10.1002/hed.23641. Epub 2014 Apr 10. Head Neck. 2015. PMID: 24677592
• A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.

  Moon SH, Cho KH, Chung EJ, Lee CG, Lee KC, Chai GY, Kang KM, Lee JY, Chung WK, Park WY, Kim JH. Moon SH, et al. Radiother Oncol. 2014 Jan;110(1):98-103. doi: 10.1016/j.radonc.2013.09.016. Epub 2013 Oct 22. Radiother Oncol. 2014. PMID: 24161568 Clinical Trial.
• Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.

  Yamazaki H, Suzuki G, Nakamura S, Yoshida K, Konishi K, Teshima T, Ogawa K. Yamazaki H, et al. J Radiat Res. 2017 Jul 1;58(4):495-508. doi: 10.1093/jrr/rrx023. J Radiat Res. 2017. PMID: 28898958 Free PMC article. Review.
• Can I treat this small larynx lesion with radiation alone? Update on the radiation management of early (T1 and T2) glottic cancer.

  Kadish SP. Kadish SP. Otolaryngol Clin North Am. 2005 Feb;38(1):1-9, vii. doi: 10.1016/j.otc.2004.10.015. Otolaryngol Clin North Am. 2005. PMID: 15649494 Review.